Kyle Robertson is out as CEO of Cerebral, the mental health startup he cofounded in January 2020. Robertson leaves the position “effective immediately” The company faces a Department of Justice investigation over its prescribing practices for controlled substances, including ADHD medications. Robertson sent an email to Cerebral staff saying the company would stop prescribing most controlled substances to new patients on May 20 and existing patients by mid-October. Cerebral’s president and chief medical officer David Mou was named CEO. Jessica Muse becomes president in addition to her current role of chief operating officer. The San Francisco-based startup was valued at $4.8 billion after a $300 million funding round led by SoftBank last December. In April, a former vice president of product and engineering . . .
Read more at www.forbes.com